The effect of vitamin D on anxiety and depression in patients with esophageal cancer

Evaluation of the effect of vitamin D on anxiety and depression in patients with esophageal cancer

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220731055593N1

Enrollment

Registered

2023-01-07

Start date

2023-01-10

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Depression. Condition 2: Anxiety. Major depressive disorder, single episode Anxiety disorder due to known physiological condition

Interventions

First Intervention group:Weekly prescription of vitamin D 50,000 units.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Esophageal cancer diagnosed at least 6 months ago Age above 18years Ability to read and write Ability to swallow oral medication

Exclusion criteria

Exclusion criteria: Pregnancy Breastfeeding Past psychological history History of drug abuse before cancer

Design outcomes

Primary

Measure	Time frame
Serum vitamin d3. Timepoint: Before - 3weeks after. Method of measurement: Serum vitamin d3.;Depression. Timepoint: Before-after. Method of measurement: Zung questionnaire.;Anxiety. Timepoint: Before-after. Method of measurement: Zung questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoume Esmaeil Pour Toroghi

Islamic Azad University

masumesp@yahoo.com+98 915 205 4542

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026